NL-OMON20226
Recruiting
Not Applicable
Performance of the Aeonose™ as a diagnostic tool to detect lung cancer: an external validation study
Medisch Spectrum Twente Enschede0 sites800 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medisch Spectrum Twente Enschede
- Enrollment
- 800
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Kort S, Brusse-Keizer M, Gerritsen JW, Van Der Palen J. Data analysis of electronic nose technology in lung cancer: Generating prediction models by means of Aethena. J Breath Res [Internet]. 2017;11(2):26006.
Investigators
Eligibility Criteria
Inclusion Criteria
- •To be eligible as a patient to participate in this study, subjects need to match the following inclusion criteria:
- •Referred for a CT scan and/or a histological biopsy due to suspicion for lung cancer.
Exclusion Criteria
- •Potential subjects will be excluded from participation in this study when meeting the following criterion:
- •Known to have an active malignancy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The electronic nose as a diagnostic tool in the discrimination of COPD and controlsNL-OMON23287Academic Medical Center Amsterdam, The Netherlands120
Not yet recruiting
Not Applicable
Breath analysis using the Aeonose to diagnose acute pulmonary embolism at the emergency departmentNL-OMON25787Medisch Spectrum Twente382
Completed
Not Applicable
An electronic nose in the screening for COPD in an at risk population of (ex-)smokers.COPD, smokingNL-OMON20180Academic Medical CenterUniversity of AmsterdamDept. Pulmonology, F5-260Meibergdreef 91105 AZ AmsterdamThe NetherlandsUniversity Medical Center UtrechtUniversity of UtrechtDept. PulmonologyHeidelberglaan 1003584 CX UtrechtThe NetherlandsThe Nelson Study Group (Nederlands-Leuvens Longkanker Screeningsonderzoek).250
Not yet recruiting
Not Applicable
E Nose.RA, reuma, rheumatoid arthritisNL-OMON28353Academisch Medisch Centrum div Immunology and Rheumatology30
Recruiting
Not Applicable
Electronic nose for breath analysis after curative Surgery to detect distant metastases or locoregional recurrence of colon cancerNL-OMON22434•The ‘Medisch Specialistisch Bedrijf’(MSB) of Isala has invested in The eNose Company, Zutphen, The Netherlands. The researchers have received a grant from the Innovation & Science fund Isala. •The eNose Company invests by making the eNose devices, disposable mouthpieces and analysis of the breath tests available.1,184